Analysis of Two Component Systems in Group B Streptococcus Shows that RgfAC and the Novel FspSR Modulate Virulence and Bacterial Fitness by Faralla, Cristina
Alma Mater Studiorum – Università di Bologna 
 
DOTTORATO DI RICERCA IN BIOLOGIA CELLULARE E 
MOLECOLARE 
 
Ciclo XXVI 
 
Settore Concorsuale di afferenza: 05/E2 
Settore Scientifico disciplinare: BIO/11 
 
Analysis of Two Component Systems in Group B Streptococcus 
Shows that RgfAC and the Novel FspSR Modulate Virulence and 
Bacterial Fitness  
 
Presentata da: Cristina Faralla 
 
Coordinatore Dottorato         Relatori 
Ch.mo Prof. Vincenzo Scarlato                 Ch.mo Prof. Vincenzo Scarlato 
                                                                   Dott. Robert Janulczyk 
 
	  
Esame finale anno 2014 
	  
	  
1 
 
 
Nobody said it would be easy, they just promised it 
would most likely be worth it 
―  Harvey MacKay 
 
 
 
Al mio amato nonno Rosario, 
che sarebbe stato fiero di vedermi raggiungere questo traguardo. 
 
 Ai miei genitori Massimo e Sissi, 
perché è grazie al loro costante supporto e sostegno che sono qui oggi. 
 
Alle mie sorelle Ida e Federica, 
perché non smettano mai di creder in loro stesse e possano realizzare 
tutti i loro sogni.
	  
	  
2 
Il mio progetto di dottorato, presentato in questo lavoro di tesi, si è focalizzato sullo 
studio dei sistemi a due componenti in Streptococcus agalactiae. Tali sistemi 
agiscono da sensori per il batterio percependo particolari stimoli ambientali e 
attivando di conseguenza una risposta intracellulare specifica (spesso di tipo 
trascrizionale). Essi rappresentano quindi uno strumento indispensabile per 
l’adattamento, la sopravvivenza e la patogenesi dei batteri.  
Nel presente lavoro, mediante un approccio combinato di bioinformatica e analisi 
trascrizionale, cinque sistemi, precedentemente poco o per nulla caratterizzati, sono 
stati scelti come target di studio. Mutanti di delezione in ognuno dei cinque sistemi 
sono stati quindi ottenuti in S. agalactiae e caratterizzati sia in vitro che in vivo. I 
risultati di tale studio sono riportati nella seguente tesi ed in un articolo attualmente in 
revisione dalla rivista MBio. 
 
Faralla C, Metruccio MM, De Chiara M*, Mu R.*, Patras KA*, Muzzi A, Grandi G, 
Margarit I, Doran KS, Janulczyk R. Analysis of two component systems in Group B 
Streptococcus shows that RgfAC and the novel FspSR modulate virulence and 
bacterial fitness. 
Under Review-MBio 
*Questi autori hanno contribuito ugualmente al presente lavoro. 
 
Parallelamente a questo progetto ho anche collaborato alla caratterizzazione 
immunologica e funzionale di uno degli antigeni scelti come candidato vaccino 
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contro Streptococcus pyogenes dalla Novartis Vaccines & Diagnostic di Siena. In 
particolare, mi sono occupata della generazione di ceppi ricombinanti di S.pyogenes 
in cui la Streptolisina-O fosse assente o sostituita con una sua forma mutata. I ceppi 
generati sono stati quindi caratterizzati in vivo al fine di investigare come questa 
proteina fosse coinvolta nell’evasione della risposta immunitaria da parte del batterio. 
Il lavoro svolto è stato oggetto di una pubblicazione scientifica. 
 
Chiarot E, Faralla C, Chiappini N, Tuscano G, Falugi F, Gambellini G, Taddei A, 
Capo S, Cartocci E, Veggi D, Corrado A, Mangiavacchi S, Tavarini S, Scarselli M, 
Janulczyk R, Grandi G, Margarit I, Bensi G. Targeted amino Acid substitutions 
impair streptolysin o toxicity and Group A Streptococcus virulence. MBio. 2013 Jan 
8;4(1). 
 
 
 
 
 
 
 
 
 
 
 
	  
	  
4 
Abstract 
Group B Streptococcus (GBS), in its transition from commensal to pathogen, will 
encounter diverse host environments and thus require coordinately controlling its 
transcriptional responses to these changes. This work was aimed at better 
understanding the role of two component signal transduction systems (TCS) in GBS 
pathophysiology through a systematic screening procedure.	   We first performed a 
complete inventory and sensory mechanism classification of all putative GBS TCS by 
genomic analysis. Five TCS were further investigated by the generation of knock-out 
strains, and in vitro transcriptome analysis identified genes regulated by these 
systems, ranging from 0.1-3% of the genome. Interestingly, two sugar 
phosphotransferase systems appeared differently regulated in the knock-out mutant of 
TCS-16, suggesting an involvement in monitoring carbon source availability. High 
throughput analysis of bacterial growth on different carbon sources showed that TCS-
16 was necessary for growth of GBS on fructose-6-phosphate. Additional 
transcriptional analysis provided further evidence for a stimulus-response circuit 
where extracellular fructose-6-phosphate leads to autoinduction of TCS-16 with 
concomitant dramatic up-regulation of the adjacent operon encoding a 
phosphotransferase system. The TCS-16-deficient strain exhibited decreased 
persistence in a model of vaginal colonization and impaired growth/survival in the 
presence of vaginal mucoid components. All mutant strains were also characterized in 
a murine model of systemic infection, and inactivation of TCS-17 (also known as 
RgfAC) resulted in hypervirulence. Our data suggest a role for the previously 
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unknown TCS-16, here named FspSR, in bacterial fitness and carbon metabolism 
during host colonization, and also provide experimental evidence for TCS-17/RgfAC 
involvement in virulence.   
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1. Introduction 
1.1 Streptococcus agalactiae 
Streptococcus agalactiae or Group B Streptococcus (GBS) is a β-hemolytic Gram-
positive bacterium first recorded as cause of fatal puerperal sepsis in 1938 (1). This 
microorganism remained then unknown until the 1970s, when it was indicated as 
responsible of a dramatic increase in the incidence of septicemia and meningitis in 
neonates (2-4). GBS was known to cause bovine mastitis before being appreciated as 
pathogenic in humans (5), even if substantial biochemical, serologic, and molecular 
differences exist between human and bovine isolates (5). In this decade, GBS remains 
the dominant cause of infant morbidity and mortality in the United States (6), and has 
also been recognized as an important cause of infections in immunocompromised 
patients and the elderly (7).  
FIG 1 Coloured scanning electron micrography (SEM) of Streptococcus agalactiae 
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GBS expresses a capsular polysaccharide (CPS) that is a major virulence factor 
contributing to evasion of host immune defense mechanisms (8). GBS CPS can be 
divided into ten serotypes (Ia, Ib, II–IX), each with unique structural and antigenic 
features. Nevertheless, all the GBS CPS repeating units share a critical conserved 
element: a terminally capped sialic acid (Sia). Sia is a nine-carbon backbone sugar 
present abundantly in the surface glycocalyx of all mammalian cells, and in this 
manner GBS decorates its surface with a common host epitope – a form of molecular 
mimicry. The sialylated CPS is recognized as a critical factor for GBS survival in 
vivo (9), interfering with host complement system functions to block C3b deposition 
and limit C5a production (10, 11). 
A number of additional virulence factors that are important for GBS adherence, 
invasion of host cells and evasion of host immunity have been described (β-
hemolysin/cytolysin, CAMP factor, superoxide dismutase, pili, C5α peptidase, serine 
proteinase, AMP) (12). Despite these advances, one area that deserves greater 
attention is how the pathogen regulates expression of these virulence factors during 
infection. GBS is a commensal in the rectovaginal tract of 20–30% of healthy women 
(13).	  	  However, by vertical transmission intrapartum, it may transition to an invasive 
pathogen, resulting in pneumonia, sepsis and meningitis (14).	  The physiopathology of 
GBS infections implies that this bacterium encounters several very different 
microenvironments during colonization and the infectious process. This indicates that 
GBS is efficiently able to adapt to changing host environments (Fig. 2). The  
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FIG 2. Lifecycle of Group B Streptococci as a neonatal pathogen. (A) GBS reside as a 
commensal in genital and lower gastrointestinal tracts of women. (B) GBS can infiltrate 
the intrauterine compartment in pregnant mothers who are asymptomatic carriers. (C) 
Newborn aspirate GBS in utero or during birth. (D) GBS invades the neonatal lung 
causing pneumonia. (E) From the lung, GBS gains access into the bloodstream of the 
neonate causing sepsis and invades multiple neonatal organs including the heart (F) GBS 
penetrates the blood brain barrier causing meningitis (12).  
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transition of the organism from a commensal niche (e.g. vaginal tract) to invasive 
niches (e.g. blood, lung, brain, and other organs) is likely to require adaptive changes, 
and a well-known way for bacteria to monitor and respond to their environment is by 
the use of two-component signal transduction systems (TCS).  
1.2 Two component systems  
TCS are typically organized in operons that encode a sensing histidine kinase (HK) 
and a response regulator (RR). The HK harbors an N-terminal input domain that 
recognizes a specific stimulus. The information is then transduced through 
intramolecular conformational changes, resulting in the phosphorylation and 
activation of the C-terminal transmitter domain. This domain, in turn, activates its 
cognate receiver, encoded by the N-terminal domain of the RR. Once activated, the 
RR gives rise to an intracellular response through the C-terminal effector (or output) 
domain. This response typically results in differential gene expression (Fig. 3), but it 
can also result in a protein-protein interaction (e.g., chemotaxis) or protein- 
DNA/RNA interactions leading to differential gene expression. Stimulus perception 
mechanisms for well-characterized HKs, can be an indication for trying to predict the 
biological function of uncharacterized TCSs, even if sequence homology is generally 
a poor predictor of sensing mechanisms or specific stimuli, while domain architecture 
may provide clues that assist in assigning HKs to one of three groups: extracellular 
sensing, membrane sensing and cytoplasmic sensing (15, 16).  
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Extracellular sensing HKs typically sense stimuli located in the extracellular space, 
like solutes or nutrients. Examples are represented by the TCSs EnvZ/OmpR (63) and 
NtrB/NtrC in E. coli. (34). Transmembrane sensing HKs usually respond to 
membrane associated stimuli such as turgor, mechanical stress, quorum sensing 
molecules or stimuli derived from membrane-bound enzymes. Classical examples are 
TCSs such as LiaS/R of B. subtilis (24) and the S. pneumoniae ComD/E (52). 
Cytoplasmic TCSs respond to diffusible or internal stimuli, such as O2 or H2. They 
also sense the presence of intracellular solutes or of proteins signaling the metabolic 
or developmental state of the cell or of the cell cycle (32). Examples are the CheA/Y 
TCS of proteobactearia (53) and ArcB/A of E.coli (31) (Fig. 4).  
A 
 
B 
 
C	  
FIG 3 TCS mechanism of action. (A) Autophosphorylation of the histidine residue (H) in 
the transmitter domain of the sensor (sensor activation); (B) Transferring of the phosphate 
group (P) to an aspartic acidic residue in the receiver domain of the RR (receiver 
activation); (C) Dephosphorylation of the RR to set the system back to the prestimulus state 
(15).  
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1.3 Two component systems in GBS	  
Overall, the role of TCS in GBS pathogenesis is not well understood and so far, only 
a few TCS have been already studied in Streptococcus agalactiae. In the sequenced 
NEM316 and 2603 V/R strains, 20 and 17 TCSs have been identified respectively 
(17, 18). The most studied system is CovRS, an important regulator in Streptococcus 
spp. In GBS, the CovRS regulon extends to 7-27% of the genome (depending on 
growth conditions), and includes different functional categories, such as cell envelope, 
cellular processes, metabolism and virulence factors (19-22).  Only a few other TCSs 
have been studied in GBS. The DltS/DltR has been showed to be involved in the 
FIG 4 Schematic representation of the three different mechanisms of stimulus perception. 
(A) Periplasmic-sensing HKs. (B) HKs with sensing mechanisms linked to the 
transmembrane regions. (C) Cytoplasmic-sensing HKs. The stimulus is represented by a red 
arrow or red star (16). 
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regulation of D-alanyl-LTA biosynthesis (23), a molecule essential for S. agalactiae 
virulence (24). The TCS RgfC/RgfA regulates the expression of bacterial cell surface 
components (ScpB) and is involved in fibrinogen binding (25, 26). In the TCS 
CiaH/R, the RR CiaR is involved in intracellular survival within neutrophils, murine 
macrophages, and human BMEC and it is linked to increased bacterial susceptibility 
to killing by antimicrobial peptides, lysozyme, and reactive oxygen species (27). 
Moreover, the Sak189 response regulator was shown to be important in controlling 
virulence properties in vivo as well as the transcription of the β-antigen through the 
bac gene (28). And just recently the two-component response regulator LiaR was 
shown to regulate expression of genes involved in microbial defence against host 
antimicrobial systems including genes functioning in cell wall synthesis, pili 
formation and cell membrane modification. Moreover GBS LiaR mutants are 
significantly attenuated in mouse models of both sepsis and pneumonia (29). 
 
1.4 Aim of the study and importance 
Two component systems have been evolved by bacteria to detect environmental 
changes and play key roles in pathogenicity. A comprehensive analysis of TCS in 
GBS has not been previously performed. 
In the present study, we aim to better understand the role of TCS in GBS patho-
physiology by adopting a step-wise screening strategy. First, inventory, comparative 
genomics analysis, and sensing mechanism classification were performed through a 
bioinformatics approach. Second, by transcriptional analysis and identification of 
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output domains related to virulence, we selected five systems and generated knock-
out strains for further study.  
In this way we classified 21 TCS and presented evidence for the involvement of two 
specific TCS in GBS virulence and colonization in vivo. Although pinpointing 
specific TCS stimuli is notoriously difficult, using a combination of techniques we 
identified two systems with different effects on GBS pathogenesis. For one of the 
systems, we propose that fructose-6-phosphate, a metabolite in glycolysis, is 
sufficient to induce a regulatory response involving a sugar transport system.  
Our catalogue and classification of TCS not only give an overview of the TCSs 
distribution in the world of group B Streptococcus but also provide new evidences of 
their importance in the fitness and virulence of GBS.	   
This work is a precious starting point and it may guide further studies into the role of 
TCS in GBS pathogenicity and biology. 
	  
	  
16 
2. Results 
 
2.1 Identification and comparative genomics of TCS 
For the purposes of our study, we focused our main attention on serotype V GBS 
isolates. Type V is the most common capsular serotype associated with invasive 
infection in non-pregnant adults and has increased among neonatal invasive disease 
strains in the recent years, accounting for approximately one-third of clinical isolates 
in the U.S. population (30). To identify possible TCS, genes predicted to encode HKs 
or RRs in the GBS type V 2603 V/R genome were collected from the P2CS database 
(http://www.p2cs.org) (31, 32). A total of 38 genes (21 systems) were identified 
(Table 1). 17 out of these loci contained a cognate pair of HK and RR-encoding genes 
while an additional 4 TCS genes were orphans. Each TCS locus, whether paired or 
orphaned, was assigned a number in order of appearance on the chromosome. The 
predicted TCS proteins were then used as queries to identify corresponding gene loci 
in 7 other GBS genomes (17, 18, 33). Eight out of 21 TCS were very well conserved 
(identity>98%) across the genomes. Our analysis was unidirectional, and we do not 
exclude the presence of additional TCS in the 7 genomes. Thirteen systems had 
critical polymorphisms in one or more genomes, and the resulting proteins were 
predicted to be functionally inactive or compromised. However, such variants were 
especially abundant in draft genomes (pseudochromosomes), and often contained 
ambiguous nucleotides or contig breaks close to the polymorphism. Therefore, some 
of the reported polymorphisms may represent sequencing errors, in which case we are 
underestimating the number of fully functional orthologous systems.  TCS-17/RgfAC 
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presented an interesting case of variability. While TCS-17/RgfAC is complete and 
conserved in strains CJB111 and COH1 (and O90R), other strains have an orphan 
TCS-17/RgfAC, where only the RR/RgfA is present. Genomes with an orphan TCS-
17 may have undergone recombinatorial events, as they show larger deletions in the 
locus with short remnants of putative hk or rr genes. Moreover, RR17/RgfA is less 
similar (80% identity) than typical (>95%) when comparing the orphaned variants 
with the paired variants. This suggests a subsequent degeneration of the inactive 
orphaned locus, or that TCS-17 in strains CJB111, COH1 and O90R could represent 
a functionally different system.  
We also searched the NCBI database of non-redundant protein sequences, and 
excluded hits in GBS. All our best hits were found in organisms that are 
phylogenetically close to GBS, and all but two were found in Streptococcus spp. 
Sequence identity varied, and a subset of the TCS may represent a ‘Streptococcal set’, 
while systems with the lowest degree of homology may perform functions unique for 
GBS.  
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TCS	   2603 V/R	   Type	   Anomalies a	   CJB111 b	   Best hit c	   Id d	   Ref.e	  
TCS-1	  
SAG0123	   RR	    SAM0116	  
S. uberis	  
100	    
SAG0124	   HK	    SAM0117	   99	    
TCS-2	  
SAG0182	   HK	    SAM0183	  
S. ratti	  
82	    
SAG0183	   RR	    SAM0184	   78	    
TCS-3 
(Orphan)	  
SAG0310	   HK	   515	   SAM0322	  
S. vestibularis	  
50	    
 -	   RR in all strains	   SAM0323	     
TCS-4	  
SAG0321	   HK	    SAM0333	  
S. iniae	  
63	   liaSR 
(29)	  SAG0322	   RR	    SAM0334	   85	  
TCS-5	  
SAG0393	   RR	    SAM0401	  
S. porcinus	  
77	    
SAG0394	   HK	   COHI	   SAM0402	   67	    
TCS-6	  
SAG0616	   RR	    SAM0583	  
E. faecalis	  
95	   sak188/
189 (28)	  SAG0617	   HK	   H36B *, 18RS21*	   SAM0584	   78	  
TCS-7 
(Orphan)	  
SAG0712	   RR	   18RS21 *	   SAM0733	  
R. albus	  
54	    
 -	       
TCS-8	  
SAG0719	   RR	    SAM0741	  
S. infantarius	  
90	    
SAG0720	   HK	   H36B	   SAM0742	   79	    
TCS-9	  
SAG0976	   RR	    SAM0983	  
S. criceti	  
73	    
SAG0977	   HK	    SAM0984	   54	    
TCS-10	  
SAG0984	   HK	    SAM0991	  
S. mutans	  
60	   ciaRH 
(27) SAG0985	   RR	    SAM0992	   89	  
TCS-11	  
SAG1016	   RR	    SAM1027	  
S. urinalis	  
49	    
SAG1017	   HK	   H36B*	   SAM1028	   67	    
TCS-12	  
SAG1327	   HK	   H36B */***	   SAM1289	  
S. gallolyticus	  
65	    
SAG1328	   RR	  
515 (RR in different 
locus)	   SAM1290	   73	    
TCS-13	  
SAG1624	   HK	   18RS21 *	   SAM1583	  
S. ictaluri	  
51	   covRS 
(21) 
	  SAG1625	   RR	    SAM1584	   85	  
TCS-14	  
SAG1791	   HK	    SAM1775	  
S. infantarius	  
57	  
dltRS 
(23)	  
SAG1792	   RR	  
CJB111*/***, 515, 
H36B*/***	   SAM1776	   73	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TABLE 1 Comparative genomics of TCS    
aStrains/genomes in which orthologous HK or RR proteins were predicted to be inactivated or 
exhibited other variations compared to the 2603 V/R strain. Genomes analyzed were A909, 
515, H36B, 18rs21, NEM316 , COH1 and CJB111;  bNon-GBS species in which the most 
similar TCS was identified (combined best score for HK and RR proteins, respectively); 
cPercent amino acid identity of HK and RR with the most similar non-GBS putative 
orthologues. Query cover  >95%; dTIGR gene names of hk and rr genes in the CJB111 strain 
used in the experimental studies; ePreviously reported name (citation); *Reduced sequence 
quality, **Sequence identity <90%, ***Minor truncation (<40 aa).  
TCS-15 
(Orphan)	  
SAG1922	   RR	    SAM1860	  
S. pneumoniae	  
64	    
      
TCS-16	  
SAG1946	   RR	    SAM1885	  
S. canis	  
77	    
SAG1947	   HK	    SAM1886	     
TCS-17 
(Orphan)	  
 -	  
HK in 
COH1,CJB111	   SAM1896	  
S. pneumoniae	  
 rgfAC 
(25) 
SAG1957	   RR	  
COH1**,  CJB111**, 
A909***, H36B	   SAM1897	   57	  
TCS-18	  
SAG1960	   HK	   18RS21	   SAM1900	  
S. bovis	  
58	    
SAG1961	   RR	    SAM1901	   72	    
TCS-19	  
SAG2054	   RR	   COH1	   SAM1962	   S. 
pseudoporcinus	  
59	    
SAG2055	   HK	    SAM1963	   71	    
TCS-20	  
SAG2122	   RR	    SAM2038	  
S. ratti	  
65	    
SAG2123	   HK	    SAM2039	   43	    
TCS-21	  
SAG2127	   HK	   18RS21	   SAM2043	  
S. porcinus	  
70	    
SAG2128	   RR	   18RS21 (Absent)	   SAM2044	   65	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2.2 Domain architecture for TCS in the genome of CJB111 
For further experimental analysis we shifted our focus to the serotype V strain 
CJB111 that is more virulent than 2603 V/R in mouse models, and for which a 
custom microarray was available in-house. The CJB111 TCS gene identified are 
listed in Table 1. We analyzed the domain architecture of all the HK proteins in the 
genome of CJB111 and predicted the mechanism of stimulus perception according to 
criteria reported in the literature (16) (Fig. 5). Nine of the HKs contained an N-
terminal domain with two transmembrane helices with a spacer of 50-300 aa, typical 
for extracellular (EX) sensing. Eight HKs contained 2-6 predicted transmembrane-
spanning regions separated by short spacers, and were predicted to be membrane 
sensing (TM). Only one HK was classified as cytoplasmic (C) sensing.  
We also observed that all the RR proteins had a DNA-binding output domain, 
indicating a role as direct transcriptional regulators. Interestingly, the LytTR output 
domain was the second most common output domain in GBS (15%), while it 
accounts for a smaller percentage (4%) in prokaryotes in general. LytTR-type output 
domains have been noted for the control of virulence factors in several important 
bacterial pathogens (32). 
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FIG 5 Domain architecture of histidine kinases. Protein sequences were analyzed using SMART  
http://smart.embl-heidelberg.de and PFAM domains were included. The scale bar shows the 
length of sequences in amino acids. Blue vertical bars represent putative transmembrane helices 
and pink squares represent low complexity regions. Various functional domains are indicated by 
the remaining colored elements and using the SMART nomenclature (e.g. GAF, PAS, HAMP, 
PAC). The SMART HATPasec domain in TCS-17/RgfAC is an outlier homolog and was found 
using the schnipsel database. Sensing mechanisms were manually predicted as TM 
(TransMembrane), EX (Extracellular) and C (Cytoplasmic). 
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2.3 Transcriptional analysis of TCS 
Transcriptional analysis was performed in early logarithmic (EL) and early stationary 
(ES) phase using a custom microarray chip designed on the CJB111 genome. We 
noted that several TCS were significantly up-regulated in ES phase, and 3 of these 
(TCS-2, TCS-16, TCS-21) were up-regulated 4- fold or more (data not shown). As 
many TCS respond to stress conditions such as those encountered in stationary phase 
(lack of nutrients, low pH, and accumulation of toxic metabolites), we hypothesized 
that these systems could be involved in bacterial stress responses and selected them 
as targets for mutagenesis. To further understand the levels of expression of each 
selected TCS during bacterial growth in vitro, we measured the gene transcripts of the 
HKs at four time points (representing early, mid-,  
FIG 6 qRT-PCR analysis of selected TCS in four different phases of growth: early (EL), mid 
(ML), and late logarithmic (LL), and early stationary phase (ES). Each column represents 
three biological replicates, and error bars show the SEM. Fold change is relative to the 
expression level of each system in EL phase. 
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TCS Name	   Type	   Fold 
change a	  
p-value b	  
TCS-2	  
SAM0183	   HK	   6.1	   7.4x10-4	  
SAM0184	   RR*	   5.6	   6.0x10-3	  
TCS -11	  
SAM1027	   RR*	   0.9	   n.s.	  
SAM1028	   HK	   1.5	   n.s.	  
TCS -16	  
SAM1885	   RR	   4.5	   3.8x10-3	  
SAM1886	   HK	   5.5	   1.1x10-3	  
TCS -17	  
SAM1896	   HK	   1.1	   n.s.	  
SAM1897	   RR*	   1.6	   n.s.	  
TCS -21	  
SAM2043	   HK	   37.0	   6.0x10-8	  
SAM2044	   RR	   19.5	   6.3x10-5	  
 
 
 
 
 
 
Table 2 CJB111 expression of selected TCS  (a)Relative expression of the TCS in ES 
compared to EL growth phase; (b)The fold change was considered not significant (n.s.) if 
p>0.05; *Contains a LytTR output domain. 
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and late logarithmic and early stationary phases) using a qRT-PCR analysis (Fig. 6). 
These data confirmed that TCS-2, TCS-16, and TCS-21 are up-regulated only in ES 
phase. 
Transcriptional regulators with the LytTR-type output domains control production of 
virulence factors in several important bacterial pathogens (32). We consequently 
selected the three TCS containing RR with a LytTR-type DNA binding domain, i.e 
TCS-2 (up-regulated at ES phase), TCS-11 and TCS-17/RgfAC, as mutagenesis 
targets. Thus, a total of five TCS exhibiting either the presence of a LytTR domain 
and/or up-regulation during ES were selected for further experimentation (Table 2). 
 
2.4 Expression microarray analysis of TCS mutants  
The 5 selected TCS loci were modified genetically by in-frame deletion of the genes 
encoding RRs. There were no apparent differences in colony size, hemolysis, or other 
macroscopic features between the wild-type strain and the five isogenic mutant 
strains on blood agar or tryptic soy agar plates (data not shown). Mutant strains 
grown in complex medium exhibited growth curves identical to the wild-type 
parental strain (Fig. 7). Global transcriptional analysis was performed by microarray 
technology. Gene expression of all the predicted genes (n=2,232) in the CJB111 
genome was performed by comparing the WT strain with each of the 5 mutant strains 
in ES phase (Fig. 8A). Experimental design, chip validation, quality control and data 
analysis were performed as described (see Materials and Methods). 
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FIG 7 Growth curves of WT and isogenic mutant strains in THB medium. Curves represent 
the mean of triplicate samples.	  
A  
      
B 
B 
FIG 8 Microarray analysis of TCS mutant strains. Columns represent the number of up- 
(green) or down-regulated (red) genes in early stationary (ES) phase, compared to the WT 
strain. Threshold used is ± 2-fold change and p≤0.05 (A). Venn Diagram showing overlap 
of gene regulation between the mutants (B). 
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Further validation of the microarray data was performed by qRT-PCR using probes 
for 9 independent transcriptional units (Fig. 9). Overall, all five mutants exhibited 
differentially transcribed genes compared to the wild type when using a permissive 
threshold (+/- 2-fold change and p<0.05). The number of regulated genes ranged from 
2 (Δrr17) to 66 (Δrr11). Two mutants (Δrr11 and Δrr21) showed predominantly 
down-regulated genes, suggesting that these RRs act as activators. We observed that 
some genes appeared regulated in two or more independent mutant strains (Fig. 8B). 
In particular, 20 genes were regulated in both Δrr21 and Δrr11 (19 genes down-
regulated and 1 gene up-regulated in both strains). A more stringent threshold was 
applied to identify the most highly regulated genes (+/- 4-fold change and p<0.05). 
Three mutants (Δrr2, Δrr11 and Δrr16) showed a total of 18 highly regulated genes 
and in two of them such genes were identified adjacent to the TCS locus (Table 3). In 
particular, the mutant Δrr2 exhibited down-regulation of SAM0185 and SAM0186, 
encoding two proteins similar to LrgAB in Streptococcus mutans. In this species 
LrgAB is reported to be under the control of an adjacent TCS (homologous to TCS-2) 
and was suggested to have a role in the control of virulence and biofilm formation 
(34, 35). The mutant Δrr16 showed strong down-regulation of an adjacent 
phosphotransferase system (PTS), and concomitant up- regulation of another PTS 
system in a different locus. All the highly regulated genes were subjected to 
confirmation by qRT-PCR, using one probe set per transcriptional unit (Table 3). 
Moreover, qRT-PCR experiments were repeated on chromosomally complemented 
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strains where the deleted rr gene was replaced with the WT form, which confirmed  
that the WT phenotype was restored (Table 3). 
 
 
FIG 9 Correlation between microarray and qRT-PCR. Values obtained for the two methods 
were plotted on the x and y axes. Each dot represents the fold change of mutant versus WT for a 
highly regulated gene indicated with an arrow. The mutant strains used were Δrr2 (red), Δrr11 
(green) and Δrr16 (blue).	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Mutant	   Name	   Annotation	   Gene	  
Fold change 
microarray	   p-value a	  
Fold change 
qRT-PCRb 
Δrr2	   SAM0185 LrgA family subfamily,putative	   lrgA	   -­‐11.5 4.0x10-5	   -6.14/-1.18	  
 SAM0186 LrgB family protein	   lrgB	   -­‐8.8 1.2x10-4	    
Δrr11	   SAM0011	  
Phosphoribosylform
yl- glycinamidine 
synthase	    -­‐4.0 2.2x10-4	    
 SAM0012	  
Amidophosphoribos
yl-transferase	   purF	   -­‐4.0 3.0x10-3	   -2.23/+2.98	  
 SAM0013	  
Phosphoribosylform
yl-glycinamidine 
cyclo-ligase	   purM	   -­‐4.3 2.4x10-4	    
 SAM0014	  
Phosphoribosylglyci
namide 
formyltransferase	   purN	   -­‐4.3 1.8x10-3	    
 SAM0064	  
Ribosomal protein 
S5	   rpsE	   -­‐4.4 1.8x10-5	   -2.01/+1.56	  
 SAM1026 Carbon starvation protein, putative	   cstA	   -­‐5.7 1.6x10-5	   -10.95/+2.11	  
 SAM1057	  
Conserved 
hypothetical protein	    -­‐5.1 1.8x10-5	    
 SAM1058	  
Conserved 
hypothetical protein	    -­‐5.2 5.8x10-5	    
 SAM1059	  
Carbamoyl-
phosphate synthase, 
large subunit	   carB	   -­‐7.4 3.0x10-7	   -4.72/-1.69	  
 SAM1060	  
Carbamoyl-
phosphate synthase, 
small subunit	   carA	   -­‐4.2 4.2x10-2	    
Δrr16	   SAM1715 PTS system, IIC component	   fruA-2	   +4.0 1.4x10-4	   +3.25/-1.06	  
 SAM1716 PTS system, IIA component	   fruA-2	   +4.1 2.6x10-4	    
 SAM1887 PTS system, IID component	    -­‐31.6 1.6x10-7	   -324.0/+1.72	  
 SAM1888 PTS system, IIC component	    -­‐72.0 1.0x10-7	    
 SAM1889 PTS system, IIB component	    -­‐55.7 1.0x10-6	   -6.14/-1.18	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 SAM1890 PTS system, IIA component, putative	    -­‐52.0 1.8x10-7	    
 
TABLE 3 Highly regulated genes in early stationary phase. (a)Inclusion threshold is p ≤ 
0.05 and fold change ± 4 (compared to WT strain). (b)Fold change of 
knockout/complemented strains compared to the WT strain.  
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2.5 Phenotype microarray screening shows that TCS-16 influences carbon 
source utilization 
Our microarray analysis showed differential regulation of two different PTS 
(SAM1715-1716 and SAM1887-1890) in the Δrr16 mutant strain, suggesting a 
possible involvement in the monitoring of carbon source availability. The WT and 
Δrr16 strains were grown on 192 different single carbon sources using the phenotype 
microarray technology (Fig. 10). One compound showed a clear difference between 
the WT and mutant strain. The WT strain exhibited growth comparable to the positive 
control when supplied with fructose-6-phosphate (Fru-6-P), while the Δrr16 strain 
showed no growth. The experiment was repeated using the complemented strain 
KIrr16, showing a growth profile indistinguishable from the WT strain (Fig. 10).  
To confirm this phenotype in an independent system, and to understand if it could be 
extended to other hexose-6-phosphate sugars, we used a chemically defined medium 
(36) where glucose, fructose, mannose, or their corresponding hexose-6-phosphate 
counter parts were used as the primary carbon source (Fig. 11). The WT, Δrr16 and 
KIrr16 strains grew well on glucose, fructose and mannose while only the WT and 
KIrr16 strains grew on Fru-6-P. The other phospho-sugars did not allow any bacterial 
growth. We concluded that TCS-16 is necessary for growth of strain CJB111 on Fru-
6-P as the primary carbon source. 
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FIG 10 Phenotype microarray analysis on WT, Δrr16 and KIrr16 was performed using PM1 and 
PM2A plates (http://www.biolog.com/pdf/pmlit/PM1-PM10.pdf). Kinetic plots are shown in red 
(WT) or in green (mutant and complemented strains), and superimposition is shown in yellow. 
Metabolic differences between WT and Δrr16 or WT and ΚΙrr16 mutant are shown in superimposed 
kinetic plots obtained by growing bacteria on PM1 (A and C) or PM2A (B and D).	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FIG 11 Growth curves of WT (blue), Δrr16(red) and KIrr16 (green) in CDM 
supplemented with 10 mg/ml of glucose (left) or glucose-6-P (right) (A), fructose (left) 
or fructose-6-P (right) (B), mannose (left) or  mannose-6-P (right) (C). Growth curves 
are from triplicate samples, and background (negative control, no sugar added) was 
subtracted.	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2.6 TCS-16 gene regulation in response to extracellular Fru-6-P 
We subsequently investigated the impact of Fru-6-P on transcription of TCS-16 and 
its adjacent PTS system by qRT-PCR. Bacteria grown in CDM were subjected to a 
substitution of glucose for Fru-6-P upon entry in mid-logarithmic phase (see 
materials and methods). The hk16 gene transcription increased 22-fold when bacteria 
are exposed to Fru-6-P compared to glucose (Fig. 12A). This response was observed 
in the WT, absent in Δrr16, and partially restored in the complemented KIrr16 strain. 
Concomitantly (Fig. 12BC), a similar pattern was observed for the adjacent PTS 
system (3,000-fold up-regulation) and for SAM1402 (2.5-fold up-regulation), a 
putative hexose-6-P transporter that we identified in the genome of CJB111. A down-
regulation of sam1402 gene (1.5-fold) in the Δrr16 strain was also observed in the 
microarray. Fru-6-P is an intracellular metabolic intermediary of the glycolytic 
pathway. Bacterial lysis constitutes a possible scenario where Fru-6-P would be 
found in the extracellular space. We wanted to investigate if TCS16 would respond 
under such conditions. Bacteria were grown in CDM until mid-logarithmic phase, 
and the medium was changed to CDM without glucose in the presence or absence of 
bacterial lysate (see materials and methods). The transcriptional levels of TCS-16, of 
its adjacent PTS system and of the putative hexose-6-P transporter were then 
analysed by qRT-PCR. The hk16 gene transcription increased 10-fold when bacteria 
were exposed to bacterial lysate compared to the control (Fig. 12D). Concomitantly, 
an  up-regulation of the PTS system (200-fold) and sam1402 gene (5-fold) was 
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observed (Fig. 12E-F). These responses were absent in Δrr16, and totally restored in 
the complemented KIrr16 strain. 
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FIG 12 qRT-PCR with probes for SAM1885 (HK) (A, D), SAM1888 (PTS, IIC 
component) (B, E), and SAM1402 (putative hexose-phosphate transporter) (C, F), 
using RNA extracted from WT (black), Δrr16 (gray) and KIrr16 (white). In the top 
panel (A-C), bacteria grown in CDM were subjected to a pulse of either glucose (Glu) 
or fructose-6-P (Fru-6-P) as the main carbon source for 30 min prior to RNA extraction. 
Columns represent relative gene expression when exposed to Fru-6-P, compared to 
when grown in glucose. In the bottom panel (D-F), bacteria grown in CDM were 
subjected to a pulse of PBS or bacterial lysate for 30 min prior to RNA extraction. 
Columns represent relative gene expression when exposed to bacterial lysate, compared 
to the PBS control. The experiment was performed twice. Columns represent technical 
triplicates, and error bars show the SEM. 
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2.7 The RR16 recombinant protein is insoluble when expressed in E. coli 
To test if the PTS system and the putative hexose-phosphate transporter where direct 
targets of the RR16 protein, we decided to perform an electrophoretic mobility shift 
assay (EMSA). For this purpose the recombinant RR16 protein (rRR16) was 
expressed in E. coli with a His-tag and purified using the classical affinity 
chromatography approach. We tested different temperatures (37-25°C), different 
induction times (2-6-8 hours), different E. coli strains (BL21 DE3, T7 express), 
different growth media (LB, Biosilta, HTMC) and different lysis condition 
(mechanical and chemical) and we set up the best conditions to obtain a soluble 
rRR16 protein. E. coli T-7 express cells transformed with pET15TEV-rRR16-His 
plasmid were grown in the Biosilta medium at 30°C and induced for 2 hours at 25°C. 
Cells were then chemically lysed and 20% of the rRR16-His protein (33 KDa) was 
found in the soluble fraction (Fig. 13A). 
The rRR16-His was then purified from the soluble fraction using a His-tag affinity 
purification strategy (Fig. 13B). Eluted fractions were then pooled, concentrated up to 
1/6 of the initial volume and quantified using the BCA method. Samples showed a 
final concentration of 0.6 µg/µl but a high number of contaminant proteins were also 
detected on the Coomassie gel. The rRR16-His protein seemed to represent only the 
20% of the total proteins in the sample (Fig. 13C). The concentration obtained was 
then too low to be used for an EMSA. 
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Figure 13 Expression and purification of the rRR16-His protein. E. coli T-7 express 
cells expressing rRR16-His protein were lysate before (NI) and after (I) IPTG induction. 
Fraction representing the total lysate (T) and the soluble part are displayed on an 
SDS/PAGE gel and stained with Coomassie blue (A).	  The elution profiles of rRR16-His 
protein from a Ni2+ column. Purification was performed only on the soluble fraction 
obtained after induction. T, the total extract; FT, flow-through fraction; W1-2, wash 
fractions; E1-2, fractions eluted with imidazole. Fractions are displayed on an 
SDS/PAGE gel and stained with Coomassie blue (B). Protein profile in the elution 
fractions after Amicon concentration. T, total extract; lane 3-4 show different amount of 
the same sample (C).The red arrow shows the 33 KDa rRR16-His protein. 
	  
	  
38 
To improve the purification protocol we needed to obtain more soluble protein. For 
this reason we decided to express the rRR16 protein fused with the His-tag and also 
with a solubility carrier, the MBP (maltose binding protein). 
E. coli BL21-DE3 cells transformed with pMal-rRR16-MBP-His plasmid were grown 
in the Biosilta medium at 30°C and induced for 8 hours at 25°C. Cells were then 
chemically lysed and almost 90% of the rRR16-MBP-His protein (70 KDa) was 
found in the soluble fraction (Fig. 14A).  
Using a His-tag affinity purification strategy the 50% of the rRR16-MBP-His protein 
was purified from the soluble fraction and treated with the TEV protease to remove 
the carrier protein (Fig. 14B). Unexpectedly, only 10% of the rRR16-MBP-His was 
successfully cleaved by the TEV, suggesting that the cleaving link was not well 
accessible for the protease (Fig. 14C). 
To then examine the presence of aggregates (or micelles), the samples obtained after 
the His-tag purification were loaded on a size exclusion chromatography column 
(SEC). As showed in Fig. 14DE two fractions were obtained. The fist one (Fig. 14D) 
was obtained at a retention time typical of 400 KDa proteins. We then hypothesized 
that in this fraction were present aggregates of rRR16-MBP-His proteins, as the main 
band on the SDS gel is a 70 KDa protein. The second one, obtained at a retention 
time typical of 40 KDa proteins, contained the MBP (arrow1 Fig. 14E) and two 
unknown smaller proteins (arrow 2-3 Fig. 14E).  
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MS analysis was unsuccessful and for some reason we were not able to identify the 
unknown proteins. In any case also this second purification approach did not allow us 
to obtain a good amount of soluble rRR16 protein. 
Figure 14 Expression and purification of the rRR16-MBP-His protein. SDS/PAGE gel and 
stained with Coomassie blue E. coli BL21 DE3 cells expressing rRR16-MBP-His protein 
were lysate before (NI) and after (I) IPTG induction. Fraction representing the total lysate 
(T) and the soluble part are displayed. The red arrow shows the rRR16-MBP-His protein 
(A).	   The elution profiles of rRR16-His protein from a Ni2+ column. Purification was 
performed only on the soluble fraction obtained after induction. S, soluble part; FT, flow-
through fraction; W, wash fraction; E1-2, fractions eluted with imidazole. The red arrow 
shows the rRR16-MBP-His protein (B). Protein profile of the E1 fraction before (lane 2) and 
after (lane 3) TEV treatment. Arrow1, rRR16-MBP-His; arrow 2, MBP-His; arrow 3 rRR16 
(C). The elution profiles of rRR16-His protein from a SEC column obtained with 130 ml of 
elution volume. Red arrows shows the  rRR16-MBP-His protein (D). The elution profiles of 
rRR16-His protein from a SEC column obtained with 200 ml of elution volume. Arrow1, 
MBP; arrow 2-3, unknown proteins analyzed using MS (E). 
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2.8 TCS-16 influences vaginal persistence in mice 
In a recent work, carbon catabolite repression in S. pyogenes was shown to influence 
asymptomatic colonization of the murine vaginal mucosa, suggesting that availability 
of carbon sources may be subject to monitoring by the bacteria (37). We subsequently 
investigated whether TCS16 could play a role in bacterial survival during 
colonization, and utilized the Δrr16 mutant strain in a mouse model of GBS vaginal 
colonization (38, 39). CD-1 mice in estrus were inoculated with ~1×107 CFU in the 
vaginal lumen and, on successive days, bacteria were recovered by swabbing and 
quantified by serial dilution and plating on selective media. Interestingly, the Δrr16 
mutant exhibited decreased persistence in the vaginal tract (Fig. 15A). The 
statistically significant differences were observed at later time points during the 
experiment (p=0.004, day 5; p=0.02, day 7), and suggested a gradual decline in 
colonization with the mutant strain while the WT remained relatively stable 
throughout the experiment. Identical experiments were performed with the remaining 
mutant strains, and results were similar to those of the WT strain, underlining that the 
phenotype seen in the Δrr16 mutant was unique among the strains tested.  
The phenotype observed above may be due to reduced fitness at the vaginal mucosa 
and/or reduced adhesion. To test the latter, we investigated bacterial adhesion to 
vaginal epithelial cells, using a previously described method (39, 40). Bacteria were 
incubated with confluent HVEC for 30 min, washed extensively, and following cell 
lysis the bacteria were enumerated. No differences were observed between the WT 
and Δrr16 strains (Fig. 15B). 
In order to test our alternative hypothesis, we attempted to at least partly mimic the 
ecological niche. Vaginal lavages were collected from CD-1 mice and inoculated 
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with ~1×106 CFU of WT or Δrr16 strains. Bacterial growth in vitro was followed by 
viable counts, and after 26 hours a statistically significant (p=0.028) difference was 
observed (Fig. 15C). The results suggested that Δrr16 exhibited impaired 
growth/survival compared to the WT strain. In a parallel control experiment, bacteria 
were incubated in PBS without any vaginal mucoid components (Fig. 15D). Both WT 
and mutant strains showed a rapid decline in viable counts and after 26 h the vast 
majority (>99.9%) of bacteria were no longer viable. This clearly showed that the 
limited presence of vaginal mucoid components was necessary to sustain survival 
and/or growth of the bacteria during the course of the experiment. 
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FIG 15 Murine vaginal colonization model. The vaginal lumen of CD-1 mice was 
inoculated with 107 CFU of WT or Δrr16 bacteria and bacterial persistence was followed 
by viable counts. Results shown are from two independent experiments. The detection limit 
is represented by a dashed line. Horizontal bars represent medians, and the Mann-Whitney 
U test was used for statistical analysis (A). Adherence to HVEC cells by WT and Δrr16 
strains. Data are expressed as the total adherent CFU recovered compared to the 
input inoculum (MOI of 1; ~1 × 105 CFU) (B).  In vitro growth of WT and Δrr16 strains 
in PBS containing vaginal fluid (C) or in PBS (D). Triplicate samples were used and error 
bars show the SEM. Statistical analysis was performed by 2-way ANOVA. 
	  
	  
43 
2.9 TCS-17/RgfAC influences virulence in a murine model of systemic infection  
To further investigate the role of the selected TCS in GBS pathogenesis, we 
compared the relative virulence of CJB111 with the Δrr mutants using an in vivo 
mouse model of infection (40, 41). CD-1 mice were infected intravenously with 1.5 x 
107 CFU of the WT or mutant strains. Bacteremia was confirmed in all mice by 
viable counts on blood samples collected 24 h post-infection, and there was no 
significant difference in bacterial loads between WT and mutant strains (data not 
shown). Over the course of infection, animals were sacrificed at individual end-points 
(when moribund) or upon termination of the experiments, and blood, brain and lung 
tissues were collected for bacterial counts. Overall, the only mutant strain with a 
virulence phenotype was Δrr17, which exhibited a significantly higher mortality 
compared to that observed during infection with the WT strain (p=0.003, Log Rank 
test) (Fig. 16A). Interestingly, no significant differences in bacterial loads were 
observed in brain, blood and lung tissues when comparing the WT and Δrr17 strain 
(Fig. 16B-D). Blood and brain tissues from mice infected with the Δrr17 strain 
contained more individual samples with very high bacterial counts, but such samples 
were exclusively from moribund mice (Fig. 16BC). None of the other mutant strains 
showed an appreciable difference compared to the WT strain (data not shown).  
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FIG 16 Murine intravenous challenge model. Kaplan-Meyer survival plot of mice infected with 
1.5×107 CFU of bacteria (A). The Log-rank test was used for statistical analysis. Bacterial counts 
(CFU) in blood (B), brain (C), and lung tissue (D) from individual mice. Horizontal bars represent 
medians. Mice were euthanized when moribund (red) or at the endpoint (black). 
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2.10 TCS-17/RgfAC shows higher duplication rate in human blood 
Our in vivo data showed no differences in the ability of WT and Δrr17 strains to 
invade the blood brain barrier (Fig.16C). This observation was also confirmed in vitro, 
using a previously described method (40). Bacteria were incubated with confluent 
hBMEC for 30 min (adherence) or for 2 hours (invasion), washed extensively, and 
following cell lysis the bacteria were enumerated. For the invasion experiment, 
bacteria and cells were incubated for other 2 hours with antibiotic before the cell lysis. 
As expected, no differences were observed between the WT and Δrr17 strains (Fig. 
17A). 
Our in vivo data showed that the Δrr17 strain is more virulent then the WT strain in a 
systemic model of infection. Moreover a higher number of CFU was detected in the 
blood of mice infected with the Δrr17 strains compared with those infected with the 
WT (Fig. 16B). Even if this difference was not statistically significant. To further 
investigate this phenotype, we compared WT and Δrr17 strains for their ability to 
grow in human blood in vitro.  
Human blood was freshly collected and inoculated with ~1×107 CFU of WT, Δrr17 
or KIrr17 strains. Bacterial growth in vitro was followed by viable counts, and after 
300 minutes a statistically significant difference was observed between WT and 
Δrr17 (Fig. 17B). In this condition, the Δrr17 strain showed a higher number of CFU 
then the WT and complemented strains suggesting a role for this TCS in bacterial 
duplication in blood. As after 300 minutes most of the blood cells should be dead, we 
wondering if the same difference could be observed at earlier time point in human 
plasma.  
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For this experiment human blood was freshly collected and then fractionating by 
centrifugation to separate the plasma. Plasma was later inoculated with ~1×107 CFU 
of WT and Δrr17 and bacterial growth in vitro was followed by viable counts. After 
60 and 180 minutes of incubation in plasma a significant difference in the duplication 
ability of Δrr17 strain was observed (Fig. 17C).  
Taken together these data suggest that the higher duplication rate of the mutant strain 
in human blood could not be due to its ability to better escape the immune system. In 
fact the Δrr17 strain seems to have an advantage in its duplication rate only when the 
blood cells are mostly dead or totally absent. 
Data shown are preliminary as they are representative of one single experiment. To 
confirm our hypothesis experiments should be repeated at least other two times with 
two different donors. 
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FIG 17 Adherence and invasion of hBMEC cells by WT and Δrr17 strains. Data are 
expressed as the total adherent CFU recovered compared to the input inoculum 
(MOI of 1; ~1 × 105 CFU) (A). Percent survival of WT (black), Δrr17 (gray) and KI
Δrr17 (white) in human blood. Data are expressed as the total CFU recovered 
compared to the input inoculum (B). Multiplication factor of WT (black) and Δrr17 
(gray) in human plasma. Data are expressed as the total CFU recovered compared to 
the input inoculum (C). Triplicate samples were used and error bars show the SEM. 
Statistical analysis was performed by Student’s T-test. 
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3. Discussion 
In the present study, we conducted genome-wide inventory, classification, and 
comparative genomics of TCS in GBS, and can conclude that they are mostly 
conserved intra-species. For several of the TCS, putative orthologues were identified 
in other Streptococcus spp. For the remaining systems, the best hits were always 
identified in bacteria that are relatively close phylogenetically. However, the degree 
of sequence identity was more limited and closer scrutiny of gene context and domain 
architecture would be required to determine the likelihood of such TCS being true 
orthologues. Such an analysis could result in the identification of TCS that are unique 
for GBS biology. In our classification of sensing mechanisms, only one HK was 
classified as cytoplasmic sensing, while this is typically a more frequent category 
(16). A comparison of the number of TCS (corrected for genome size) in various 
pathogenic and non-pathogenic Lactobacillales spp. was also performed. In the nine 
species examined, GBS and S. pyogenes showed the highest frequency of TCS with a 
median of 38 and 36 TCS components respectively (data not shown), compared to a 
typical range of 15-32 for the other Lactobacillales. This suggests that the two 
pathogens may require particular fine-tuning of transcription in response to changing 
environments. 
Transcriptome analysis was performed on five selected systems, and we observed a 
limited number of genes that were highly regulated for three TCS. TCS-2 regulates 
the adjacent lrgAB operon, similar to what has been described for S. mutans (35). 
TCS-11 regulates genes involved in purine metabolism and carbon starvation. TCS-
16 highly regulates two PTS operons, and is discussed in more detail below.  
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TCS-17/RgfAC has already been described in GBS strain O90R, where it negatively 
regulates transcription of C5a peptidase (scpB), a known virulence factor (25). 
Moreover, an independent group demonstrated that in CC17 strains RgfAC 
negatively regulated the fbsA gene, encoding fibrinogen binding proteins (26). FbsA 
may have a role in protecting the bacteria against opsonophagocytosis, promoting 
adhesion to lung epithelial cells, and increasing survival in human blood (42, 43). We 
did not observe any up-regulation of the above genes in the Δrr17 strain, which may 
be due to differences in the experimental protocol (time points) or in the genetic 
background (CJB111 belongs to CC1 (44)). Nonetheless, the Δrr17 strain was 
hypervirulent in our murine model of systemic infection, consistent with a potential 
up-regulation of virulence factors in the absence of this transcriptional regulator.  
The second system of particular interest was TCS-16. Transcriptome analysis showed 
prominent down-regulation of an adjacent operon that encodes a putative PTS 
(Man/Fru/Sor family) and concomitant up-regulation of another PTS (Fru family). 
TCS-16 was classified as an extracellular sensing system, and we hypothesized that it 
may be involved in monitoring and responding to the availability of nutrients (16). 
When bacteria were subjected to a large variety of different carbon sources in 
chemically defined medium, one compound, Fru-6-P, resulted in a complete growth 
defect, which was fully restored when the Δrr16 was complemented. Further 
experiments in vitro, using phosphorylated and non-phosphorylated hexose sugars 
confirmed these results. We thus conclude that a functional TCS-16 is necessary for 
growth on Fru-6-P. Investigation of the transcriptional events in the locus showed 
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that there is induction of TCS-16 upon exposure to extracellular Fru-6-P, and 
concomitantly a drastic up-regulation of the adjacent PTS operon. As the Δrr16 strain 
showed no such response, while the complemented strain exhibited a partial 
restoration, we conclude that a functional TCS-16 is necessary for autoinduction and 
regulation of the adjacent PTS operon. We propose that extracellular Fru-6-P is a 
signal for TCS-16, and that the gene locus be named fspSR, for fructose-six-
phosphate sensor histidine kinase and response regulator. Despite the magnitude of 
the influence on PTS transcription, the growth defect observed in Δrr16/ΔfspR is 
difficult to explain in terms of a direct link between the up-regulated PTS and 
utilization of Fru-6-P as an energy source. To our knowledge, PTS-dependent import 
of phosphorylated sugars has not been described. However, other such uptake 
mechanisms are known, and UhpT (major facilitator superfamily) in E.coli represents 
an example where the controlling TCS (UhpAB) is necessary for growth of E. coli 
upon Glu-6-P and Fru-6-P (45, 46). We identified a homologue of UhpT in the 
genome of CJB111 (SAM1402), and analysis of the protein suggests it could function 
as a hexose-6-P transporter (http://www.tcdb.org/). SAM1402 was among the genes 
significantly down-regulated in the Δrr16/fspR transcriptome and subsequent 
experiments confirmed that TCS-16/FspSR up-regulates sam1402 in response to 
extracellular Fru-6-P. The biological relevance of our link between Fru-6-P and TCS-
16/FspSR is difficult to ascertain, as the availability of Fru-6-P in the extracellular 
milieu is presumably limited or unknown. Nevertheless, our in vivo screening showed 
reduced vaginal persistence of the Δrr16/ΔfspR strain in mice, and a slight but 
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significant decrease in overall fitness when exposed to vaginal fluid components ex 
vivo. Interestingly, the presence of such unknown mucoidal components was 
necessary for survival/growth of the bacteria in vitro, when compared to the PBS 
control. PTS and associated carbon metabolism pathways may have an impact on in 
vivo fitness and virulence, as previously demonstrated for several different pathogens 
(47-51). One possibility is that Fru-6-P may be released from dying microorganisms 
in the complex microbiota of the vagina, or in stationary phase in vitro cultures, and 
GBS could consequently initiate a scavenging response involving up-regulation of 
sugar transporters. This hypothesis was supported by our data showing that there is an 
induction of the TCS-16 response upon exposure to bacterial lysate. This response 
was observed in the WT and complemented strains but not in the Δrr16/ΔfspR strain, 
confirming that a functional TCS-16 is necessary to up-regulate sugar transporters in 
the presence of lysed GBS components. Moreover in a previous work using a 
different strain, the PTS operon above, together with several other PTS were highly 
down-regulated in high-glucose conditions, supporting a role for this and similar 
systems in conditions where nutrients are relatively scarce (20). Another speculative 
possibility is that FspSR may be activated upon entry/invasion of eukaryotic cells, 
through the presence of Fru-6-P as a central metabolite in glycolysis. 
. 
	  
	  
52 
We have listed and classified TCS in GBS for further study and conclude that these 
TCS are very well-conserved intra-species. Our results provide new insights on four 
previously unknown TCS, but also provide the first in vivo data supporting a role for 
RgfAC in virulence. Finally we identified FspRS, a new TCS involved in vaginal 
persistence and that responds to fructose-6-phosphate by the up-regulation of genes 
involved in sugar transport. 
Fig.18 Model of TCS-16 working in response to Fru-6-P sugar.	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4. Materials and Methods 
 
4.1 Bacterial strains and growth conditions  
GBS CJB111 (Carol Baker Collection, Division of Infectious Diseases, Baylor 
College of Medicine, Houston). and its isogenic derivatives were grown in Todd-
Hewitt broth (THB medium; Difco Laboratories) at 37°C, 5% CO2. Tryptic soy broth 
(Difco Laboratories), 15 g/L agar (TSA) was used as solid medium. MAX 
Efficiency® DH5α™ Competent Cells (Invitrogen) were used for transformation, 
propagation, and preparation of plasmids. E. coli was grown at 37°C with agitation 
(180 rpm) in Luria-Bertani (LB, Difco laboratories) broth, or on 15 g/L agar plates 
(LBA) Erythromycin (Erm) was used for selection of GBS (1 µg/ml) or E. coli (100 
µg/ml) containing the pJRS233-derived plasmids used for mutagenesis (see below). 
Strains CJB111, CJB111Δrr16 and CJB111ΚΙrr16 were also grown in CDM (36), or 
CDM where glucose was substituted with 10 g/L glucose-6-phosphate, fructose, 
fructose-6-phosphate, mannose or mannose-6-phosphate (Sigma). Briefly, bacteria 
grown on THB plates were suspended in 5 ml of PBS until optical density at 600 nm 
(OD600) reached 0.3. Samples were then diluted 1:10 in PBS and 88 µl of bacteria 
were added to 1.2 ml of medium with or without different carbon sources. Bacteria 
were grown in 96-well plates with 200 µl per well for 48 h at 37°C and OD600 was 
monitored automatically every 20 min in an automated reader (Sunrise, Tecan). 
 
4.2 Construction of TCS isogenic mutants  
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To construct each knock out strain, the shuttle vector pJRS233 (52) containing the 
TCS locus with an in-frame deletion in the response regulator gene (rr) was 
constructed using a splicing by overlap extension PCR (SOEing-PCR) strategy (Table 
4) (53). Briefly, the up- and downstream region of a rr gene were produced from 
CJB111 gDNA and then joined. The resulting fragment was cloned into pJRS233 
using BamHI and XhoI restriction sites.  
Five plasmids, each containing an insert with 700-800 bp upstream and downstream 
of the in-frame deleted rr gene were obtained: pJRS233Δrr2, pJRS233Δrr11, 
pJRS233Δrr16, pJRS233Δrr17 and pJRS233Δrr21. The CJB111 genes thus 
inactivated were SAM0184 (rr2), SAM1027 (rr11), SAM1885 (rr16), SAM1897 
(rr17), and SAM2044 (rr21). 
To construct the respective chromosomally complemented knock-in (KI) strains, the 
wild type locus was amplified and cloned into pJRS233 using BamHI and XhoI 
restriction sites (Table 4). These plasmids were designated pJRS233KIrr2, 
pJRS233KIrr11, pJRS233KIrr16, pJRS233KIrr17 and pJRS233KIrr21.  
An insertion/duplication and excision mutagenesis strategy was used to obtain either 
the in-frame deletion in the response regulator genes or the chromosomal replacement 
in the knockout mutants. In brief, pJRS233Δrr2/Δrr11/Δrr16/Δrr17/Δrr21 purified 
from E. coli were used to transform CJB111 by electroporation as previously 
described (54), except that we used M9 medium without glycine and casamino acids. 
Transformants were selected by growth on TSA + Erm at 30°C for 48 hours. 
Integration was performed by growth of transformants at 37°C (non-permissive 
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temperature for the suicide shuttle vector) with Erm selection. Excision of the 
integrated plasmid was performed by serial passages in THB at 30°C, and parallel 
screening for Erm-sensitive colonies on plate. Mutants were verified by PCR 
sequencing of the TCS loci. We thus obtained five knockout strains, each having an 
inactivated response regulator gene of a specific TCS: CJB111Δrr2, CJB111Δrr11, 
CJB111Δrr16, CJB111Δrr17 and CJB111Δrr21. Or, in short, Δrr2 etc. 
To obtain the chromosomally complemented strains, plasmids 
PJRS233ΚΙrr2/KΙrr11/ΚΙrr16/ΚΙrr17/ΚΙrr21 were purified from E. coli and 
complementation of the respective mutant strains was performed as described above. 
The end result was replacement of the deleted rr gene with the WT form. The 
complemented strains were designated CJB111ΚΙrr2; CJB111ΚΙrr11; CJB111ΚΙrr16; 
CJB111ΚΙrr17; CJB111ΚΙrr21. Or, in short, KIΔrr2 etc. 
 
4.3 Recombinant RR16 cloning, expression and purification 
The expression plasmids pET15TEV (Novagen) and pMAL-c4X (Invitrogen vector 
modified in house) were used to clone the rRR16 protein fused respectively with a 
His tag and a His-MBP-TEV tag at its N-terminal region. Plasmids were previously 
modified in house to clone proteins using the PIPE strategy (55). Briefly, rr gene was 
produced from CJB111 gDNA (i-PCR).  Plasmids were linearized by PCR (v-PCR), 
mixed with the insert in a ratio of 1:3 and used to transform E. coli HK-100 
competent cells (Table 4). The resulting constructs were analyzed by DNA 
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sequencing and expressed in E. coli T7 express (pET15TEV-rRR16-His) (Invitrogen) 
or E. coli BL21(DE3) (pMal-rRR16-MBP-His) cells resistant to phage T1 (NEB).  
The cells were grown in EnBase (Biosilta) medium in shaking flasks at 30°C for 16 
hours of cultivation, until OD600 about 15, and then induced with 1 mM IPTG for 2 
hours (pET15TEV-rRR16-His) or 8 hours (pMal-rRR16-MBP-His) at 25°C. 
Afterwards the cells were harvested by centrifugation at 6000 rpm for 30 min. The 
soluble proteins were extracted using the cell lytic buffer (Sigma) and centrifuged 40 
min at 9000 rpm to remove the cell debris. Protein affinity purification was 
performed on a FF-Crude His-Trap HP nickel chelating column (GE Healthcare) pre-
equilibrated with the binding buffer (Tris-HCl (pH=8) 20 mM, NaCl 300 mM, 
Imidazole 10 mM). 
 The proteins were eluted with 300 mM imidazole; at the end of the Immobilized 
Metal Ion Affinity Chromatography (IMAC) all the fractions obtained were analyzed 
by SDS-PAGE.  
For the pMal-rRR16-MBP-His purification, the eluted protein was concentrated by 
ultrafiltration with amicon (Millipore) and the buffer was exchanged using a PD-10 
desalting column (GE Healthcare) equilibrated with TEV cleavage buffer (Tris-HCl 
50 mM (pH 8), DTT 1 mM, EDTA 0.5 mM). His-MBP-tag was cleaved by 
incubation with TEV protease. The second step of purification was performed by size 
exclusion chromatography using HiLoad 26/60 Superdex 200 (GE Healthcare) 
equilibrated in Tris-HCl 25 mM  (pH=8) and NaCl 150 mM. The proteins were 
quantified with the BCA assay (Pierce). 
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4.4 Bioinformatics methods 
The identification of histidine kinases (HKs) and response regulators (RRs) of 
putative TCS in the genome of GBS 2603 V/R was carried out using the P2CS 
(http://www.p2cs.org) database (31). A TCS was defined as an orphan if the 
predicted HK or RR genes had no adjacent partner in the locus, or if the cognate 
partner contained mutations (e.g. stop codons or frameshifts) that compromised the 
predicted gene product.  
Orthologue analysis was performed by using the BLASTp algorithm with default 
settings on complete and draft genomes of GBS strains A909, 515, H36b, NEM316, 
18rs21, COH1 and CJB111 (21-23). Loci encoding putative orthologues were 
examined manually for the gene context, which in the vast majority of cases was 
identical. The orthologues identified were then examined manually for detection of 
polymorphisms that would result in significant alterations of the gene product. 
Overall sequence quality was also inspected, and the presence of ambiguous 
nucleotides or a contig break within 100 bp of a polymorphism was taken as an 
indication of questionable sequence quality. HK and RR proteins from 2603 V/R 
were then used as queries in a BLASTp search of a database of non-redundant protein 
sequences, and the best non-GBS hits were examined. The best ‘combined hit’ was 
defined as the cognant HK/RR pair in one species with the lowest product of the two 
corresponding individual E values. 
Functional domains in each HK protein were identified by SMART and/or PFAM 
(http://smart.embl-heidelberg.de). Subsequently, HKs were manually assigned a 
signaling mechanism according to proposed criteria (16). Extracellular sensing HKs  
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typically have two TM helices with an intervening extracytoplasmic domain of 50 to 
300 aa, lacking large cytoplasmic linker regions; transmembrane sensing HK are 
characterized by the presence of 2 to 20 transmembrane regions connected by very 
short intra- or extracellular linkers; cytoplasmic-sensing HKs include either 
membrane-anchored proteins that do not fulfill the criteria above and where input 
domains (e.g. PAS, GAF) are localized on the intracellular side, or, soluble HKs with 
no transmembrane regions. 
 
4.5 Expression microarray analysis  
Expression microarray analysis was performed using a custom-made Agilent 60-mer 
oligonucleotide microarray. Oligonucleotide sequences were selected with the 
Agilent eArray system, using 6 probes per gene. The complete set of annotated genes 
(2,232) in the CJB111 genome was thus covered (http://cmr.jcvi.org/cgi-
bin/CMR/GenomePage.cgi?org=gbscjb111). The chip layout was submitted to the 
EBI ArrayExpress and is available with the identifier AMEX-BBB. RNA samples 
used for microarray analysis were prepared as follows. Bacteria for RNA extraction 
were grown in triplicate cultures (five mutant strains and the isogenic WT strain), on 
three separate occasions. Hence, for each strain, nine independent GBS cultures (nine 
biological replicates obtained in three separate days) served as the source of RNA. 
Bacteria were harvested twice: at OD600=0.3 (EL phase) and OD600=1.8-1.9, (ES 
phase, ~ 15 min into growth arrest). To rapidly arrest transcription, 10 ml of bacteria 
were cooled on ice and added to 10 ml of frozen THB medium in a 50 ml conical 
tube. GBS cells were then collected by centrifugation for 15 min at 4000 rpm, 4°C, 
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and resuspended in 800 µl of TRIzol (Invitrogen). Bacteria were disrupted 
mechanically by agitation with Lysing matrix B in 2 ml tubes (DBA Italy) using a 
homogenizer (Fastprep-24, Millipore) for 60 sec at 6.5 m/s for two cycles, and kept 
on ice for 2 min between the cycles. Samples were then centrifuged for 5 min at 8000 
x g, 4°C and RNA was extracted with Direct-zol™ RNA MiniPrep kit (Zymo 
Research) according to the manufacturer’s instructions. RNA samples were treated 
with DNase (Roche) for 2 h at 37°C and further purified using the RNA MiniPrep kit 
(Qiagen), including a second DNase treatment on the column for 30 min at room 
temperature (RT), according to the manufacturer’s instructions. 5 µg of pooled RNA 
from each triplicate were labeled (CY5-DCTP/CY3-DCTP, Euroclone) and purified 
(Wizard®SV Gel and PCR Clean-Up System; Promega). RNA thus labeled from the 
three independent days of RNA extraction was then pooled and used for microarray 
analysis. Labeling, chip hybridization, wash, scanning and data extraction were 
performed according to the procedures described by Agilent for two-color 
microarray-based gene expression analysis. After data acquisition, slide 
normalization was performed by a lowess (locally weighted scatterplot smoothing) 
algorithm, as implemented by the Agilent Feature Extraction software v.9.5.3. 
Average log ratio of fluorescence signals (M = log2(Cy5/Cy3)) of probes 
corresponding to the same gene were computed within each slide. Student’s T-test 
statistics was performed to test for differentially expressed genes. The expression 
dataset was submitted to the EBI ArrayExpress and it is available with the identifier 
AMEXP-CCC. 
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4.6 qRT-PCR analysis 
cDNA was prepared using the Reverse Transcription System (Promega) by using 500 
ng of RNA per reaction. Real time quantitative PCR (qRT-PCR) was performed on 
50 ng of cDNA that was amplified using LightCycler® 480 DNA SYBR Green I 
Master, (Roche). Reactions were monitored using a LightCycler® 480 instrument and 
software (Roche). The transcript amounts in each condition were standardized to an 
internal control gene (gyrA) and compared with standardized expression in the wild-
type strain (ΔΔCT method). Validation of microarray data by qRT-PCR was 
performed on a selection of 9 genes differentially expressed in mutant strains, using 
the RNA prepared for microrarray analysis (see above) and primers reported in Table 
4. Moreover, we prepared new RNA samples from WT, knock-out and 
complemented strains (three biological replicates obtained in three different days) to 
generate cDNA for qRT-PCR confirmation of highly regulated genes.  
For RNA extraction from bacteria grown with different carbon sources, strains were 
first inoculated in CDM and grown at 37°C until OD600=0.5. Cultures were harvested 
by centrifuging at 4000 x g, 4° C, for 10 min, and each pellet was resuspended in 10 
ml of CDM (36) without glucose and split in two. Each 5 ml sample was then 
supplemented with 10 mg/ml of glucose or fructose-6-phosphate. Bacteria were then 
incubated for 30 min at 37°C and RNA was extracted as described for the microarray 
analysis. 
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Bacterial lysate was obtained from a 10 ml culture of the WT strain in late 
logarithmic phase (OD=1). Briefly, bacteria resuspended in PBS were disrupted 
mechanically by agitation with Lysing matrix B in 2 ml tubes (DBA Italy) using a 
homogenizer (Fastprep-24, Millipore) for 60 sec at 6.5 m/s for four cycles. Tubes 
were kept on ice for 2 min between the cycles. Samples were centrifuged for 5 min at 
8000 x g, 4°C and the supernatant was collected and designated lysate. For the RNA 
extraction, strains were grown in CDM until OD600=0.5, harvested, split in two, and 
resuspended in 5 ml of CDM without glucose. Each sample was supplemented with 
800 µl of PBS or with 800 µl of lysate for 30 min at 37°C before RNA extraction.  
 
4.7 Phenotype Microarray analysis 
Phenotype Microarray (PM) technology uses the irreversible chemical reduction of a 
patented dye as a reporter of active metabolism (56). Strains CJB111, Δrr16 and 
ΚΙrr16, were used with microplates PM1 and PM2A (Biolog), testing 192 different 
single carbon sources. Bacteria on THB agar plates were scraped off and suspended 
in 5 ml of inoculation fluid (IF-0; Biolog) to an OD=0.3. Samples were then diluted 
1:10 in IF-0 to obtain a turbidity of 85% (OD~0.02-0.03), and kept on ice. Growth 
media constituents were prepared according to Biolog’s procedures for ‘S. agalactiae 
and other Streptococcus species’. PM microplates were inoculated by adding 100 µl 
bacterial suspension/well and then incubated for 48 h at 37°C in an OmniLog reader 
(Biolog). Data points were collected every 15 min. Data were then analyzed using the 
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OmniLog software. Unspecific background (well A1 in each plate, negative control) 
was subtracted from the other samples.  
 
4.8 In vivo infection experiments 
Animal studies were approved by the Office of Lab Animal Care at San Diego State 
University and conducted under accepted veterinary standards. Animal experiments 
were performed in compliance with the Novartis Animal Health & Welfare guidelines. 
We adopted a previously described murine model of hematogenous GBS meningitis 
(41), with the difference that preliminary dose-ranging experiments established the 
LD50 dose of CJB111 as 1.5 × 107 CFU per mouse (outbred 6-week old male CD1, 
Charles River laboratories). The mice were followed for 2 weeks. Also, since 
histopathology was not performed, we thus considered the experiment a model of 
systemic infection. 
The in vivo mouse model of GBS vaginal colonization has been described previously 
(39). Female CD1 mice (8-16 weeks old) were obtained from Charles River 
Laboratories and used for colonization assays.  
 
4.9 In vitro infection experiments 
The immortalized human vaginal epithelial cell (HVEC) line was obtained from the 
American Type Culture Collection 129 (ATCC CRL-2616) (57). In vitro adhesion 
was performed as previously described (39) and passages 5-10 were used for all cell 
assays. Cells were maintained at 37°C in a 5% CO2 atmosphere in keratinocyte 
serum-free medium (KSFM) (Invitrogen). 
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The human brain microvascular endothelial cell line hBMEC, which has been 
immortalized by transfection with the SV40 large T antigen (58), was obtained from 
Kwang Sik Kim (Johns Hopkins University, Baltimore, Maryland, USA). hBMEC 
maintain the morphologic and functional characteristics of primary brain endothelial 
cells (59, 60). The cells were maintained in RPMI 1640 medium (Life Technologies 
Inc., Grand Island, New York, USA) supplemented with 10% FBS, 10% NuSerum 
(Becton, Dickinson and Co., Bedford, Massachusetts, USA), MEM nonessential 
amino acids, and penicillin-streptomycin and were incubated at 37°C in 5% CO2.	  Cell 
maintenance and assays for GBS hBMEC adherence, invasion, and intracellular 
survival were performed as described previously (60, 61).  For all experiments, 
hBMECs were used at passage 8–14. 
 
4.10 Ex vivo GBS growth experiments 
Growth of CJB111 and CJB111Δrr16 was assessed ex vivo in murine vaginal lavage 
fluid. Lavage fluid was collected from female CD1 mice (8 weeks old) without any 
GBS exposure by pipetting 20 µL of PBS into the vaginal lumen several times. 
Lavage fluid was pooled and stored at -20⁰C. Bacterial strains were grown to 
exponential phase (approximately 1×108 CFU/mL) in THB, washed, diluted 1:100 in 
PBS, and 90 µL was combined with 10 µL vaginal lavage fluid. Samples were 
collected at indicated time points and plated on THB agar to determine viable CFU. 
Growth of CJB111; CJB111Δrr17 and CJB111KIΔrr17 was assessed ex vivo in 
human blood and  human plasma. Blood was freshly collected from one donor the 
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morning of the experiment. All strains to be tested were grown on TS agar plates at 
37°C and 5% CO2 overnight. Bacteria were inoculated in THB liquid medium to an 
OD of 0.05 at 600 nm and grown to early-log phase	  (OD of 0.5–0.6); then, they were 
concentrated to ∼109 CFU/ml in PBS. The assay was started by the addition of the 
bacterial suspension (10 µL∼107 CFU) to 100% whole human blood (340 µL) in 2 ml 
tubes. Cultures were incubated at 37°C and 5% CO2 with gentle agitation; at various 
time points (30, 60, 180 and 300 minutes), an aliquot of the sample was removed, and 
the number of viable bacteria was determined by plating serial dilutions onto TS Agar 
(Difco) and incubating overnight at 37°C and 5% CO2. 
Experiments were performed in duplicate. Whole venous blood, collected from 
healthy individuals and anticoagulated with heparin (5 U/mL), was used. 
Survival in human plasma was performed using human plasma collected from human 
blood after centrifugation at 1000 x g, 4°C for 15 minutes in 15 ml tubes. The 
experiment was then performed as described for the one in human blood. 
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4.11 Oligo list 
Oligo	  name a Sequence	  (5’	  to	  3’)	  b	   Application	  
F184soe1 CTGGGATCCGGGATAACAGAGGAACAA mutagenesis rr2 
R184soe1 ACCTACTGGGGCAAACATTTCATCATCAAGAAT mutagenesis rr2 
F184soe2 ATGTTTGCCCCAGTAGGTCGATCGTATTTAAAA mutagenesis rr2 
R184soe2 TGACTCGAGCCAAAGAATGACAATACCACT mutagenesis rr2 
F1027soe1 AAGGATCCGATCACATGCTTCATTGACTT mutagenesis rr11 
R1027soe1 TATTGTATGCGCTCTTACATTGTGAACATTAAT mutagenesis rr11 
F1027soe2 GTAAGAGCGCATACAATACCTTTCTAATTTTTAAT mutagenesis rr11 
R1027soe2 TTCTCGAGGCACAACATATGACTTACGTT mutagenesis rr11 
F1885soe1 AACGGATCCACCACTTTTTTGCAAATTGAC mutagenesis rr16 
R1885soe1 GATGAGGGTCAGACAGTAAAAGCGTTT mutagenesis rr16 
F1885soe2 TGTCTGACCCTCATCCTCAACGATAAGTAATCT mutagenesis rr16 
R188 soe2 CACTCGAGCTGGTCGTCCTTTTTTCTCTA mutagenesis rr16 
F1897soe1 TAGGATCCCTCAATATGGTGGCTATAATC mutagenesis rr17 
R1897soe1 CAGGCAGGTTCGAATTGTTTGATTTCTCGT mutagenesis rr17 
F1897soe2 ATTCGAACCTGCCTGTTGAATAAAATTATCCTC mutagenesis rr17 
R1897soe2 ATACTCGAGCTGAAACCATTAAAGCCAGAT mutagenesis rr17 
F2044soe1 TATGGATCCCGTTCCTACCGTAATAAAGGT mutagenesis rr21 
R2044soe1 TTTACCACCGGGGTCATCATCAATAATATAGAA mutagenesis rr21 
F2044soe2 GACCCCGGTGGTAAAATTTCACTTAAACGTTTT mutagenesis rr21 
R2044soe2 TTGCTCGAGCTTACCTTCCTTAATAACACAAAT mutagenesis rr21 
F183 GTCAGTTACGCGCAGTTCAA qRT-PCR  
R183 GCCTCTTTATAATTTCGCAAACG qRT-PCR 	  
F1028 CCTGTTCCAATTCATCATGAAGA qRT-PCR 	  
R1028 GGATAGCGAAAAAGCAAGAAAG qRT-PCR 	  
F1886 GATGCGATCGGCTAGAACT qRT-PCR 	  
R1886 CACGATCATCGAGCTTTTGTTG qRT-PCR 	  
F1896 GTCGGAAATGTGTATTAGATTCTT qRT-PCR 	  
R1896 CCACCATATTGAGGGGTTGT qRT-PCR 	  
F2045 GGTCAACTTCAGCCGTCAAA qRT-PCR 	  
R2045 GTGAACGTCCCGCGAAATAT qRT-PCR 	  
F1888 CCGCAAACCATCAAGGTAAAC qRT-PCR 	  
R1888 TCAGGTTTTGAGGAATATGATGG qRT-PCR 	  
F1715 GGTCCCATTTCAGCCTTTAC qRT-PCR  
R1715 TTCAATGGTCCTCCAAGGTC qRT-PCR  
F0011 TGTCATTGAAGCGACAGCTC qRT-PCR  
R0011 AACGCTCTGCCTGTTTATCC qRT-PCR  
F1026 TGGTTTCCATGCTACCCAAG qRT-PCR  
R1026 CTGCAATCATCATGCCGTAG qRT-PCR  
F1800 TTACAGCATGCGGAAACG qRT-PCR  
R1800 TTTTGCTTCTCCGACTGAGC qRT-PCR  
F1061 TGCTCTAGGATTGGACGTTTG qRT-PCR  
R1061 GTGATTGGCTTGGATGTTGG qRT-PCR  
F0185 TCACTACCAATCCCAACGAC qRT-PCR  
R0185 AAGCCCCAAAAGAGTCAACC qRT-PCR  
F1402 TCGGACTTCCGCCTATAGAA qRT-PCR  
R1402 TACAAGGATGCCCACATCAG qRT-PCR  
F0012 TGACCCTAATGCCTTTCGTC qRT-PCR  
R0012 ACTTCGCCAGGTTCAACATC qRT-PCR  
F0064 CGTGTTGGTTTTGGTACAGG qRT-PCR  
R0064 CGTGAGGAATTGTTGTACCG qRT-PCR  
F1059 TGCAGAGCAAATCGGGTATC qRT-PCR  
R1059 TTAACCCCTTCGTCGTGATG qRT-PCR  
F0965 AGGTTTACTTGTGGCGCTTG qRT-PCR-gyrA 
R0965 TCTGCTTGAGCAATGGTGTC qRT-PCR-gyrA 
F1885Pipe CTGTACTTCCAGGGCTATAGATTACTTATCGTTGAGGATGAGCAC PIPE-iPCR 
R1885Pipe AATTAAGTCGCGTTAATCCATCTGTTTAAAAATATGTTCTTCCTTAAAC PIPE-iPCR 
FpMal TAACGCGACTTAATTTAACTTAATTAAATTTCAGAATTCGGA PIPE-vPCR 
RpMal GCCCTGGAAGTACAGGCCCTGGAAGTACAGGTTTTC PIPE-vPCR 
FpET TAACGCGACTTAATTCTAGCATAACCCCTTGGGGCCTCAAACGG PIPE-vPCR 
RpET GCCCTGGAAGTACAGGTTTTCGTGATGATGATGATGATGGCTGCTGCCC
ATGGTATATC 
PIPE-vPCR 
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TABLE 4: a Numbers refer to the CJB111 gene designations (http://cmr.jcvi.org); b 
BamHI and XhoI restriction sites (underlined) and complementary nucleotides used for 
PCR SOEing or for PIPE (bold) are shown.  
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